PACTR201706002208408招募中未知
Translating Research into Practice (TRIP): Evaluating and Speeding up the adoption of an evidenced based innovative REMSTART package to reduce mortality in advanced stage HIV patients starting antiretroviral therapy in Tanzania
iverpool School of Tropical Medicine (LSTM)0 个研究点目标入组 620 人开始时间: 2017年4月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 620
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Year(s) 至 100 Year(s)（—）
- 性别
- All
入选标准
- •The inclusion criteria will be:
- •-CD4<200 cells /¿l
- •-Serum/plasma CrAg positive
- •-Lumbar puncture negative
- •-Adult: ¿18y or more.
- •-Antiretroviral naïve (as reported by the patient)
- •-Planning to remain in the study area for about 6 months (as reported by the patient)
排除标准
- •The exclusion criteria will be:
- •-requiring immediate in-patient care / admission
- •-Pregnant or lactating
- •-If ALT > 5 times upper limit of normal
研究者
相似试验
招募中
不适用
Translational research associated with 'An investigator-initiated phase II trial of niraparib for patients with BRCA-mutated unresectable/recurrent biliary tract, pancreatic and other gastrointestinal cancer'biliary tract, pancreatic and other gastrointestinal cancersJPRN-UMIN000049452Hokkaido University Hospital60
尚未招募
Unknown
Implementing Kangaroo Mother Care soon after birth in district hospitalsCTRI/2023/03/050420Centre for Health Research and Development Society for Applied Studies
已完成
不适用
The use of health belief derived interventions to improve the ability of patients to take medicines for pulmonary arterial hypertensioPulmonary arterial hypertension (PAH)Circulatory SystemISRCTN41973090niversity of Bradford33
招募中
1 期
An Interventional and Translational Study investigating Sotorasib in Previously Treated Locally Advanced or Metastatic NSCLC Subjects With Mutated KRAS p.G12C (CODEBREAK)locally-advanced and unresectable or metastatic NSCLC with KRAS G12CMedDRA version: 21.1Level: PTClassification code: 10061873Term: Non-small cell lung cancer Class: 100000004864MedDRA version: 25.1Level: LLTClassification code: 10069759Term: KRAS mutation Class: 10018065CTIS2024-510837-16-00Institut Gustave Roussy40
进行中（未招募）
1 期
An Interventional and Translational Study investigating Sotorasib in Previously Treated Locally Advanced or Metastatic non-small-cell lung cancerocally-advanced and unresectable or metastatic non-small-cell lung cancer with KRAS G12C mutationEUCTR2021-006958-31-FRGustave Roussy40